Search results
Found 12698 matches for
Researchers at the University of Oxford led by DPAG's Professor Peter Robbins are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die when oxygen levels in their arterial blood fall to levels that are too low to support life.
Bionanoscience
A multidisciplinary field that combines nanoscience, nanotechnology, and biology
Neuroscience
We host a number of internationally recognised neuroscience groups, with expertise in a wide range of experimental and computational methods.
Metabolism & Endocrinology
We use the full range of modern molecular genetic and imaging techniques to study a range of metabolic areas.
Functional Genomics
We play a leading role in the development of more efficient and cost-effective sequencing technologies.
Development & Cell Biology
We dissect the molecular and cellular mechanisms underlying a range of developmental and reproductive processes.
Cell Physiology
We study everything from the structure of ion channels and transporters right up to their role in behaviour and human disease.
Cardiac Sciences
We are recognised internationally for our pioneering approaches to systems biology and to computational modelling of the heart.